Role of N6-methyladenosine methylation in glioma: recent insights and future directions
Abstract Glioma is the most pervasive intracranial tumor in the central nervous system (CNS), with glioblastoma (GBM) being the most malignant type having a highly heterogeneous cancer cell population. There is a significantly high mortality rate in GBM patients. Molecular biomarkers related to GBM...
Main Authors: | Chunlin Li, Bowen Li, Hui Wang, Linglong Qu, Hui Liu, Chao Weng, Jinming Han, Yuan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | Cellular & Molecular Biology Letters |
Subjects: | |
Online Access: | https://doi.org/10.1186/s11658-023-00514-0 |
Similar Items
-
RNA N6-methyladenosine methylation and skin diseases
by: Yaqin Yu, et al.
Published: (2023-12-01) -
Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
by: Yujia Chen, et al.
Published: (2022-03-01) -
N6-methyladenosine RNA methylation: From regulatory mechanisms to potential clinical applications
by: Peipei Li, et al.
Published: (2022-11-01) -
The emerging roles of N6-methyladenosine RNA methylation in human cancers
by: Huafei Shen, et al.
Published: (2020-06-01) -
Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer
by: Qiang Liu
Published: (2022-01-01)